← Back to Search

Peer Mentoring [PM] for Sickle Cell Disease (ST3P-UP Trial)

N/A

Waitlist Available

Led By Raymona Lawrence, DRPH

Research Sponsored by Ifeyinwa (Ify) Osunkwo MD MPH

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at baseline, 6, 12, 18, 24, 30, 36, 42, 48, and 54 months post study initiation

Awards & highlights

ST3P-UP Trial Summary

This trial will compare adding virtual peer mentoring to a structured education-based transition program for people with sickle cell disease to see if it decreases the number of acute care visits, improves patient-reported outcomes, and reduces healthcare utilization.

Eligible Conditions

Sickle Cell Disease

ST3P-UP Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at baseline, 6, 12, 18, 24, 30, 36, 42, 48, and 54 months post study initiation

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at baseline, 6, 12, 18, 24, 30, 36, 42, 48, and 54 months post study initiation

This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, 6, 12, 18, 24, 30, 36, 42, 48, and 54 months post study initiation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of acute care visits

Secondary outcome measures

Adults Sickle Cell Quality of Care Measure (ASCQ-ME QOC) for health-related quality of life

Health Care Transition Feedback Survey

Medical Outcomes Study Social Support Survey (MOS-SSS)

+6 more

Other outcome measures

Health Care Transition Process Measurement Tool Score

ST3P-UP Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Structured Education Based Transition Program + Peer MentoringExperimental Treatment2 Interventions

Structured Education Based Transition Program [STE] + Peer Mentoring [PM]

Group II: Program Structured Education Based Transition ProgramActive Control1 Intervention

Program Structured Education Based Transition Program [STE]

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Levine Cancer InstituteUNKNOWN

5 Previous Clinical Trials

377 Total Patients Enrolled

Ifeyinwa (Ify) Osunkwo MD MPHLead Sponsor

Patient-Centered Outcomes Research InstituteOTHER

549 Previous Clinical Trials

29,996,197 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers still enrolling volunteers in this venture?

"As indicated on the clinicaltrials.gov website, this particular medical experiment is not presently enrolling participants. It was initially posted in January 2018 and last updated May 2022; however, there are 198 other trials that are currently seeking volunteers."

Answered by AI

In what capacity is this trial managed across different sites?

"This investigation is currently registering participants at Wake Forest Baptist Hospital in Winston-Salem, North carolina, East Carolina University in Greenville, Virginia and the VCU Medical Center in Richmond. Additionally, there are 14 other locations enrolling patients for this trial."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

LCI-HEM-SCD-ST3P-UP-001: The Sickle Cell Trevor Thompson Transition Project (ST3P-UP Study)

Ifeyinwa (Ify) Osunkwo MD MPH 2019. "LCI-HEM-SCD-ST3P-UP-001: The Sickle Cell Trevor Thompson Transition Project (ST3P-UP Study)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03593395.